Berkshire Hathaway Inc. remains a Buy with robust earnings, solid equities portfolio, and a strong cash position. Learn more ...

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.

The conglomerate beat analysts' operating profit target, but there were no share buybacks over the third quarter.

Investors shouldn't replicate the concentration of Berkshire, but the following stocks could have a place in your portfolio.

Investors have long followed Buffett and team's stock picks via a massive portfolio within Berkshire Hathaway. Today, that ...

Shares of the Tylenol maker jumped by nearly one-fifth in premarket trading on the news that Kimberly-Clark (KMB) would ...

Warren Buffett's Berkshire Hathaway has been stacking up cash, selling stocks such as Apple, and holding off on buybacks ...

Berkshire Hathaway is holding a record $381.7 billion in cash, signaling a cautious approach to equity markets as the company ...

The firm said cash and equivalents reached a record roughly $382 billion as of Sept. 30, up from about $344 billion in the ...

Individual investors should take note of Buffett's current caution.

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Despite Berkshire Hathaway being a net seller of stocks for the past three years, Warren Buffett would never sell these two ...